Optimal follow-up of endometrial cancer patients

被引:0
|
作者
Vrdoljak E. [1 ]
Boraska Jelavić T. [1 ]
Petrić Miše B. [1 ]
机构
[1] Clinic for Oncology and Radiotherapy, Clinical Hospital Centre Split, Spinčićeva 1, Split
关键词
Cancer; Endometrial; Follow-up; Gynecological; Recurrence;
D O I
10.1007/s12254-015-0202-z
中图分类号
学科分类号
摘要
Gynecological malignancies account round 10 % of all female cancers, with the uterine cancer being the most predominant one. Surveillance programs of all gynecologic cancers are primarily based on recurrence rates, timing of recurrence, salvage options and chances for cure of patient with recurrence. Since there is no prospective, high evidence data about optimal surveillance program after primary treatment of patients with endometrial cancer recommendations are based on review of retrospective data sets. From all the diagnostic tools available, history taking and clinical examination, including comprehensive gynecological examination, still contribute to the greatest number of recurrence detection. Radiologic tests are usually employed when a suspicion of recurrence is raised. Follow-up plan should be tailored according to the estimated risk of relapse for individual patient. © 2015, Springer-Verlag Wien.
引用
收藏
页码:62 / 65
页数:3
相关论文
共 50 条
  • [41] The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
    Angioli, Roberto
    Capriglione, Stella
    Scaletta, Giuseppe
    Aloisi, Alessia
    Miranda, Andrea
    Nardone, Carlo De Cicco
    Terranova, Corrado
    Plotti, Francesco
    [J]. TUMOR BIOLOGY, 2016, 37 (04) : 4973 - 4978
  • [42] Risk-specific follow-up for endometrial carcinoma patients
    Shumsky, AG
    Brasher, PMA
    Stuart, GCE
    Nation, JG
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 65 (03) : 379 - 382
  • [43] AN EVALUATION OF ROUTINE FOLLOW-UP OF PATIENTS TREATED FOR ENDOMETRIAL CARCINOMA
    SHUMSKY, AG
    STUART, GCE
    BRASHER, PM
    NATION, JG
    ROBERTSON, DI
    SANGKARAT, S
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 55 (02) : 229 - 233
  • [44] Reccomendations for diagnosis, treatment and follow-up of patients with endometrial carcinoma
    Barbara, Segedin
    Sebastjan, Merlo
    Spela, Smrkolj
    Sonja, Bebar
    Ana, Blatnik
    Olga, Cerar
    Branko, Cvjeticanin
    Barbara, Gazic
    Andreja, Gornjec
    Borut, Kobal
    Mateja, Krajc
    Ksenija, Strojnik
    Manja, Sesek
    Erik, Skof
    Iztok, Takac
    Ales, Vakselj
    Vesna, Zadnik
    Barbara, Zobec Logar Helena
    [J]. ONKOLOGIJA, 2018, 22 (01) : 96 - 114
  • [45] Relapse of Endometrial Carcinoma: Follow-up of 272 Patients with Relapse
    Lindahl, Bengt
    Ranstam, Jonas
    Willen, Roger
    [J]. ANTICANCER RESEARCH, 2012, 32 (08) : 3391 - 3395
  • [46] FOLLOW-UP IN CASES OF ENDOMETRIAL CARCINOMA
    ZIPPEL, HH
    FERVERSSCHORRE, B
    [J]. GYNAKOLOGE, 1983, 16 (02): : 119 - 122
  • [47] Stratified follow-up for endometrial cancer: a move to more personalized cancer care
    Sarwar, Asma
    Van Griethuysen, Jennifer
    Waterhouse, Jasmine
    Dehbi, Hakim-Moulay
    Eminowicz, Gemma
    McCormack, Mary
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (12) : 1564 - 1571
  • [48] What is the "Optimal" follow-up schedule for ICD patients?
    Senges-Becker, JC
    Klostermann, M
    Becker, R
    Bauer, A
    Siegler, KE
    Katus, HA
    Schoels, W
    [J]. EUROPACE, 2005, 7 (04): : 319 - 326
  • [49] What is the "optimal" follow-up schedule for ICD patients?
    Senges-Becker, JC
    Klostermann, M
    Becker, R
    Weretka, S
    Siegler, KE
    Schoels, W
    [J]. CIRCULATION, 2003, 108 (17) : 616 - 616
  • [50] An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer
    Gadducci, A
    Cosio, S
    Fanucchi, A
    Cristofani, R
    Genazzani, AR
    [J]. ANTICANCER RESEARCH, 2000, 20 (3B) : 1977 - 1984